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Abstract
We report a rare case of synchronous duodenal carcinoma, colonic carcinoma and renal oncocytoma successfully
treated using a one-stage surgical approach. Potential risk factors for multiple primary malignancies associated with
duodenal carcinoma are discussed. This case illustrates several practice points for consideration: 1. Patients
presenting with small intestinal carcinomas have a higher than average chance of developing second primary
tumors in other organs; this should be taken into consideration during staging and follow-up. 2. For full staging of
patients presenting with small bowel tumors, upper and lower gastrointestinal endoscopy and PET scanning
should be considered. 3. A one-stage surgical procedure can be used safely and successfully for multiple
synchronous primary tumors.
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Background
Primary carcinomas of the duodenum, excluding carci-
noma of the ampulla of Vater, have been reported to
occur in 0.019-0.5% of all autopsies and in 35-45% of all
cases of small intestinal cancer [1,2]. There have been
few reported cases in the literature of multiple synchro-
nous primary cancers of the duodenum and colon
although a large population-based study has suggested
that patients diagnosed with primary duodenal carci-
noma have a higher than expected incidence of second
primary malignancy [3]. We are reporting a case of syn-
chronous duodenal and colonic carcinomas plus a renal
oncocytoma successfully resected using a one-stage sur-
gical approach.
Case Report
A 67 year old male presented with a history of weight
loss and generalized weakness of 2 months duration.
General investigations revealed anemia with hemoglobin
of 9.2 g/dl. Upper gastrointestinal endoscopy was
unremarkable, lower gastrointestinal endoscopy revealed
a rectal polypoid mass (2.5 cm) with wide base, 12 cm
from the anal verge (Figure 1). Biopsy of the mass
revealed a moderately differentiated adenocarcinoma.
Endoscopic rectal ultrasound confirmed the extension of
the tumor to the muscularis propria and subserosa with
no enlarged lymph nodes (T3N0). Staging computed
tomography (CT) of chest, abdomen and pelvis showed
a 4.7 × 3.6 cm mass in the pancreatic head with infiltra-
tion of the duodenum, and a left kidney mass (3 cm)
suspicious of renal cell carcinoma (Figure 2). A positron
emission tomography (PET) scan showed increased
uptake in the pancreatic head mass (13 SUV) and in the
rectal mass (12 SUV) with no uptake in the renal mass.
The biochemical profile included the following: white
blood count 7,700/μl, hemoglobin level 9.2 g/dl, protein
of 35 g/dl, CEA = 1.17 ng/ml and CA 19-9 = 20 U/ml.
A detailed family history was negative for malignancy.
The patient underwent a pancreaticoduodenectomy
for the periampullary tumor, low anterior resection for
the rectal tumour and partial nephrectomy for the renal
tumour after an intraoperative frozen section revealed
the presence of an oncocytoma.
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mosis: The pancreatic anastomotic reconstruction was
via a loop of jejunum which was anastomosed to the
pancreas in an end to side; duct to mucosa fashion,
using 4/0 Polydioxanone (PDS) sutures. The biliary ana-
stomosis was performed using 4/0 (PDS) sutures in an
interrupted fashion end to side with the same jejunal
loop. The gastro-jejunal anastomosis was performed in
an end to side fashion using 3/0 PDS. The colonic
anastomosis was performed with an EEA stapler. The
operative time was 6 hours with minimal blood loss.
Pathology of the periampullary tumor revealed a mod-
erately differentiated duodenal adenocarcinoma with 10
benign peri-pancreatic lymph nodes. Pathology of the
colonic tumour showed a moderately differentiated infil-
trating adenocarcinoma reaching but not crossing the
muscularis propria with eight benign pericolonic lymph
nodes (T2N0M0). Final pathology of the kidney mass
was oncocytoma with had been completely excised.
The patient recovered well postoperatively and was
discharged home.
Discussion
Primary adenocarcinoma of the duodenum is very rare
with an incidence of 0.035% of all gastrointestinal can-
cers [4]. It constitutes approximately 35-45% of small
bowel cancer and presents in patients in their 5
th and
6
th decade with a median age of 55 years [5,6]. Multiple
primary tumors of the duodenum and colon are also
uncommon due to the rarity of duodenal cancer. In
1932, Warren and Gates set the criteria for multiple pri-
mary malignant tumors [7]. Presently, it is agreed on
that each tumor must acquire specific features of malig-
nancy, must be separate, and the possibilities that one
tumor is a metastatic lesion deriving from another
tumor must be excluded. Our case met these criteria;
therefore we concluded that it is a case of multiple pri-
mary cancers.
The etiology and pathogenesis of small bowel and
duodenal cancer is poorly understood. Several risk fac-
tors have been identified including Crohn’s disease,
familial adenomatous polyposis (FAP), celiac sprue, cys-
tic fibrosis and colon cancer [8,9]. Several reports
describe ampullary cancers as secondary primaries in
patients with a history of colonic cancer in the setting
of FAP [9,10]. Others describe secondary small bowel
cancers with hereditary nonpolyposis colon cancer syn-
drome (HNPCC) [11]. Minniet al describes an increase
incidence of small intestinal tumors; including duodenal
adenocarcinoma, in patients with sporadic colonic
malignancy [12].
Data from 13 cancer registries from Europe and
Canada was analyzed in terms of incidence of second
primary cancers following a diagnosis of small intestinal
malignancy. This study reported a 68% overall increase
in the risk of a new primary cancer after small intestinal
carcinoma [3]. Increases were observed for cancers of
the oropharynx, colon, and rectum, ampulla of Vater,
pancreas, uterus, ovary, prostate, kidney, thyroid gland,
skin and soft tissue sarcomas. The authors concluded
that the apparent increase in risk may be partly attribu-
table to overdiagnosis, genetic and environmental factors
Figure 1 CT scan showing the thickenned wall of the rectum
suggesting the presence of rectal carcinoma.
Figure 2 CT scan of the abdomen showing the pancreatic
tumor and the left renal oncocytoma.
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implicated in the HNPCC syndrome was increased after
carcinoma of the small intestine and for colorectal, pan-
creatic and endometrial cancer the increased risk was
mainly after early-onset small intestine cancer. The
authors suggest that this supports the hypothesis that
defects in mismatch repair and other DNA repair path-
ways, not necessarily leading to well characterized syn-
dromes such as HNPCC, are common genetic features
of cancers of the small intestine and other associated
organs.
Dietary factors, alcohol consumption and high body
mass index which are known risk factors for colon can-
cer are possibly acting as risk factors for small bowel
adenocarcinoma in the same individual [3]. Renal onco-
cytoma is a benign epithelial tumor with excellent out-
come. More than half of the patients are diagnosed
incidentally. Those who present with symptoms usually
present with abdominal pain, a palpable mass and gross
hematuria. Nephron-sparing or partial nephrectomy is
the accepted treatment for lesions less than 4 cm in dia-
meter [13,14]. The pre-operative PET scan performed in
this case showed the pancreatic head and rectal lesions
to be equally FDG-avid however the renal lesion did not
take up FDG. The sensitivity of PET for the detection of
renal cell carcinoma has been debated however a recent
study has shown a relatively high sensitivity and specifi-
city compared to previous smaller reports [15]. In this
case the lack of FDG uptake in the renal lesion demon-
s t r a t e dt h a ti tw a sn o tar e n a lm e t a s t a s i sf r o mo n eo f
the others tumors; however a malignant renal lesion
could not be excluded.
Conclusions
In conclusion, we are presenting an unusual case report
of a patient presenting with three synchronous primary
tumors who treated with a successful on-stage surgical
approach.
This case illustrates several practice points:
1. Patients presenting with small intestinal carcino-
mas have a higher than average chance of developing
second primary tumors in other organs; this should
be taken into consideration during staging and fol-
low-up.
2. The use of upper and lower gastrointestinal endo-
scopy and consideration of PET scanning for full sta-
ging of patients presenting with small bowel tumors.
3. A one-stage surgical procedure can be successfully
used for multiple synchronous primary tumors.
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